Fidelity Investments
TENX icon

Fidelity Investments’s Tenax Therapeutics TENX Stock Holding History

Fidelity Investments’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.4M Buy
3,942,373
+3,619,773
+1,122% +$46.2M ﹤0.01% 1460
2026
Q1 		$5.16M Buy
322,600
+181,500
+129% +$2.46M ﹤0.01% 2296
2025
Q4 		$1.72M Buy
+141,100
New +$1.23M ﹤0.01% 2664
2024
Q3 		– Sell
-1
Closed -$3 – 5723
2024
Q2 		$3 Buy
+1
New +$4 ﹤0.01% 5332

Other funds holding TENX

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Fidelity Investments's TENX Position: Q2 2026 in Review

Fidelity Investments increased its Tenax Therapeutics (TENX) stake by 1,122% in Q2 2026, buying an estimated $46.2M and bringing the position to 3,942,373 shares worth $57.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

Fidelity Investments first reported a position in TENX in Q2 2024 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Fidelity Investments held 3,942,373 shares of Tenax Therapeutics worth $57.4M as of Q2 2026.
  • Fidelity Investments bought 3,619,773 Tenax Therapeutics shares in Q2 2026, an estimated $46.2M.
  • Tenax Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1460 holding.
  • Fidelity Investments first reported a position in Tenax Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.